-
Views
-
Cite
Cite
News and Reviews, The Journal of Clinical Endocrinology & Metabolism, Volume 97, Issue 9, 1 September 2012, Pages 23A–24A, https://doi.org/10.1210/jcem.97.9.zeg23a
- Share Icon Share
Extract
The U.S. Food and Administration approved Qsymia (phentermine and topiramate extended-release) to complement a reduced-calorie diet and exercise for chronic weight management. This drug is the second weight loss drug the agency has approved this year.
(www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312468.htm)
People who frequently complain of sleep apnea, insomnia, and daytime sleepiness were significantly more insulin-resistant than those who slept better, according to a questionnaire and oral glucose tolerance test study of 796 adults without type 2 diabetes.
(Diabetes Care [printed online July 26, 2012])
Postmenopausal women reported greater limitations in physical function than premenopausal women; these results were independent of age and only partially explained by body mass index and depressive symptoms.
(Menopause [published online July 2, 2012])
Subtotal thyroidectomy for Graves disease was cost-effective, compared to radioactive iodine and thyroid surgery, when the initial postoperative euthyroid rate was greater than 49.5%.
(Surgery [August 2012] 152(2):164)
Two-thirds of severely obese children, even those less than 12 years of age, had cardiovascular risk factors such as hypertension, high blood glucose, type 2 diabetes, and low HDL-cholesterol, according to a Dutch prospective surveillance study of 500 children with newly diagnosed severe obesity.